Minimal-change Nephrotic Syndrome in a Hematopoietic Stem-cell Transplant Recipient
Overview
Affiliations
Background: A 61-year-old woman received standard immunizations, including Haemophilus influenzae type B, diphtheria, tetanus toxoid, and unconjugated 23-valent pneumococcal vaccine (Pneumovax), Merck & Co., Inc., Whitehouse Station, NJ), 1 year after undergoing nonmyeloablative hematopoietic stem-cell transplantation for acute myelogenous leukemia. After 5 days, she developed fatigue with progressive weight gain and edema, and 14 days after immunization she presented with anasarca and was found to have acute renal failure and nephrotic proteinuria.
Investigations: Physical examination, serum chemistry, examination of urine sediment, renal ultrasound using Doppler scanning, 24 h urine collection, and renal biopsy.
Diagnosis: Minimal-change nephrotic syndrome with acute tubular injury.
Management: Aggressive diuresis and oral corticosteroid therapy.
De Novo Immunoglobulin A Vasculitis Following Exposure to SARS-CoV-2 Immunization.
Mohamed M, Wickman T, Fogo A, Velez J Ochsner J. 2022; 21(4):395-401.
PMID: 34984055 PMC: 8675622. DOI: 10.31486/toj.21.0083.
Monoclonal antibodies for podocytopathies: rationale and clinical responses.
Marasa M, Kopp J Nat Rev Nephrol. 2009; 5(6):337-48.
PMID: 19474828 DOI: 10.1038/nrneph.2009.70.
Stem cell mobilization in idiopathic steroid-sensitive nephrotic syndrome.
Lapillonne H, Leclerc A, Ulinski T, Balu L, Garnier A, Dereuddre-Bosquet N Pediatr Nephrol. 2008; 23(8):1251-6.
PMID: 18458957 DOI: 10.1007/s00467-008-0793-2.